William Blair Keeps Their Hold Rating on Lantheus (LNTH)
William Blair analyst Andy Hsieh reiterated a Hold rating on Lantheus (LNTH – Research Report) today. The company’s shares opened today at ...
Nektar Therapeutics’ (NKTR) “Market Perform” Rating Reaffirmed at William Blair
William Blair reiterated their market perform rating on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a report issued on Tuesday,RTT News reports. Other research analysts have also ...